Literature DB >> 18582832

Is the pneumococcal polysaccharide vaccine effective in preventing pneumonia?

Angel Vila-Corcoles.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18582832     DOI： 10.1016/S1473-3099(08)70134-8

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN： 1473-3099            Impact factor:   25.071


× No keyword cloud information.
  4 in total

1.  Severe community-acquired pneumonia and PIRO: a new paradigm of management.

Authors:  Jordi Rello; Thiago Lisboa; Richard Wunderink
Journal:  Curr Infect Dis Rep       Date:  2009-09       Impact factor: 3.725

2.  Cost of pneumococcal infections and cost-effectiveness analysis of pneumococcal vaccination at risk adults and elderly in Turkey.

Authors:  Levent Akin; Mehmet Kaya; Serdar Altinel; Laure Durand
Journal:  Hum Vaccin       Date:  2011-04-01

Review 3.  Effectiveness and practical uses of 23-valent pneumococcal polysaccharide vaccine in healthy and special populations.

Authors:  Yang Wang; Jingxin Li; Yuxiao Wang; Wei Gu; Fengcai Zhu
Journal:  Hum Vaccin Immunother       Date:  2017-12-21       Impact factor: 3.452

4.  Rationale and design of the CAPAMIS study: effectiveness of pneumococcal vaccination against community-acquired pneumonia, acute myocardial infarction and stroke.

Authors:  Angel Vila-Corcoles; Inmaculada Hospital-Guardiola; Olga Ochoa-Gondar; Cinta de Diego; Elisabet Salsench; Xavier Raga; Cruz M Fuentes-Bellido
Journal:  BMC Public Health       Date:  2010-01-19       Impact factor: 3.295
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.